MaPGAS Decision Making
Launched by DARTMOUTH-HITCHCOCK MEDICAL CENTER · Aug 20, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study aims to evaluate the usability, acceptability, and preliminary efficacy of a novel, web-based decision aid (DA) for Metoidioplasty and Phalloplasty Gender Affirming Surgeries (MaPGAS).
MaPGAS are increasingly performed to improve gender congruence and quality of life, however, patients face complex decisions which may impact fertility, urinary and sexual function. Existing decisional uncertainty among transgender and non-binary individuals considering MaPGAS highlights the need for effective decision support tools. Prior research indicates a gap in validated decision support, pa...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Assigned female on the original birth certificate.
- • Self-identifies as transgender male and/or gender non-binary.
- • Able to speak, read, and understand English at a sixth-grade level.
- • Aged 18 or older.
- • Resides in the USA.
- • For decision aid refinement: Considering metoidioplasty or phalloplasty, or is post-operative.
- • For intervention and control arm: Has a consultation scheduled for metoidioplasty or phalloplasty.
- Exclusion Criteria:
- • Participants involved in the initial tool refinement focus groups cannot participate in the intervention or control group to avoid contamination of the study outcomes.
About Dartmouth Hitchcock Medical Center
Dartmouth-Hitchcock Medical Center (DHMC) is a leading academic medical institution located in Lebanon, New Hampshire, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a major teaching hospital affiliated with the Geisel School of Medicine at Dartmouth, DHMC integrates cutting-edge clinical trials and translational research into its comprehensive patient care approach. The center emphasizes collaboration across disciplines, aiming to enhance patient outcomes through rigorous scientific investigation, education, and community engagement. With a focus on ethical practices and patient safety, DHMC is dedicated to contributing to the advancement of medical knowledge and improving health care delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
Hanover, New Hampshire, United States
Patients applied
Trial Officials
Rachel A. Moses, MD, MPH
Principal Investigator
Dartmouth-Hitchcock Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported